搜索临床试验以:PD-L1肽
总计3507个结果
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
Shanghai Cell Therapy Research Institute未知
-
Yunnan Cancer Hospital招聘中
-
Shanghai Jiao Tong University Affiliated Sixth...招聘中
-
Shanghai Zhongshan Hospital主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人晚期恶性实体瘤 | 难治性恶性实体瘤 | KRAS基因突变 | 转移性恶性实体瘤 | 表皮生长因子受体基因突变 | ERBB2基因扩增 | ERBB2基因突变 | EGFR基因扩增 | ERBB3基因突变 | ERBB4基因突变美国
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of Medical Sciences尚未招聘
-
Sichuan Cancer Hospital and Research Institute主动,不招人
-
The Affiliated Hospital of Qingdao University未知
-
Hangzhou Cancer HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Zhejiang Cancer Hospital尚未招聘胃癌、HIPEC、抗 PD-1 抗体 Camrelizumab (SHR-1210)、化疗和手术中国
-
National Institute of Allergy and Infectious Diseases...招聘中
-
Hangzhou Hanx Biopharmaceuticals, Ltd.Wuhan Hanxiong Bioscience, Ltd.主动,不招人
-
Tianjin Medical University Cancer Institute and...招聘中
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of Medical Sciences尚未招聘
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Agenus Inc.; Dutch Cancer Society尚未招聘
-
BioAtla, Inc.招聘中
-
GlaxoSmithKline完全的
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)完全的
-
First People's Hospital of HangzhouHangzhou Cancer Hospital招聘中
-
Shandong New Time Pharmaceutical Co., LTD未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital of Shantou University... 和其他合作者招聘中